Compare NXTS & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NXTS | PRFX |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 2.7M |
| IPO Year | N/A | 2020 |
| Metric | NXTS | PRFX |
|---|---|---|
| Price | $0.69 | $2.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 53.2K | 27.6K |
| Earning Date | 03-27-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.65 | $0.58 |
| 52 Week High | $1.10 | $3.71 |
| Indicator | NXTS | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 25.50 | 39.32 |
| Support Level | $0.65 | $1.28 |
| Resistance Level | $1.10 | $3.65 |
| Average True Range (ATR) | 0.10 | 0.23 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 13.72 | 8.99 |
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.